Cargando…

Long‐term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study

BACKGROUND: The long‐term course of ulcerative colitis after a severe attack is poorly understood. Second‐line rescue therapy with cyclosporine or infliximab is effective for reducing short‐term colectomy but the impact in the long‐term is controversial. OBJECTIVE: The purpose of this study was to e...

Descripción completa

Detalles Bibliográficos
Autores principales: Festa, Stefano, Scribano, Maria L., Pugliese, Daniela, Bezzio, Cristina, Principi, Mariabeatrice, Ribaldone, Davide G., Allocca, Mariangela, Mocci, Giammarco, Bodini, Giorgia, Spagnuolo, Rocco, Vernia, Piero, Mazzuoli, Silvia, Costa, Francesco, Barberio, Brigida, Cosintino, Rocco, Zerboni, Giulia, Aratari, Annalisa, Armuzzi, Alessandro, Papi, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259429/
https://www.ncbi.nlm.nih.gov/pubmed/33259773
http://dx.doi.org/10.1177/2050640620977405
_version_ 1783718667218845696
author Festa, Stefano
Scribano, Maria L.
Pugliese, Daniela
Bezzio, Cristina
Principi, Mariabeatrice
Ribaldone, Davide G.
Allocca, Mariangela
Mocci, Giammarco
Bodini, Giorgia
Spagnuolo, Rocco
Vernia, Piero
Mazzuoli, Silvia
Costa, Francesco
Barberio, Brigida
Cosintino, Rocco
Zerboni, Giulia
Aratari, Annalisa
Armuzzi, Alessandro
Papi, Claudio
author_facet Festa, Stefano
Scribano, Maria L.
Pugliese, Daniela
Bezzio, Cristina
Principi, Mariabeatrice
Ribaldone, Davide G.
Allocca, Mariangela
Mocci, Giammarco
Bodini, Giorgia
Spagnuolo, Rocco
Vernia, Piero
Mazzuoli, Silvia
Costa, Francesco
Barberio, Brigida
Cosintino, Rocco
Zerboni, Giulia
Aratari, Annalisa
Armuzzi, Alessandro
Papi, Claudio
author_sort Festa, Stefano
collection PubMed
description BACKGROUND: The long‐term course of ulcerative colitis after a severe attack is poorly understood. Second‐line rescue therapy with cyclosporine or infliximab is effective for reducing short‐term colectomy but the impact in the long‐term is controversial. OBJECTIVE: The purpose of this study was to evaluate the long‐term course of acute severe ulcerative colitis patients who avoid early colectomy either because of response to steroids or rescue therapy. METHODS: This was a multicentre retrospective cohort study of adult patients with acute severe ulcerative colitis admitted to Italian inflammatory bowel disease referral centres from 2005 to 2017. All patients received intravenous steroids, and those who did not respond received either rescue therapy or colectomy. For patients who avoided early colectomy (within 3 months from the index attack), we recorded the date of colectomy, last follow‐up visit or death. The primary end‐point was long‐term colectomy rate in patients avoiding early colectomy. RESULTS: From the included 372 patients with acute severe ulcerative colitis, 337 (90.6%) avoided early colectomy. From those, 60.5% were responsive to steroids and 39.5% to the rescue therapy. Median follow‐up was 44 months (interquartile range, 21–85). Colectomy‐free survival probability was 93.5%, 81.5% and 79.4% at 1, 3 and 5 years, respectively. Colectomy risk was higher among rescue therapy users than in steroid‐responders (log‐rank test, p = 0.02). At multivariate analysis response to steroids was independently associated with a lower risk of long‐term colectomy (adjusted odds ratio = 0.5; 95% confidence interval, 0.2–0.8), while previous exposure to antitumour necrosis factor‐α agents was associated with an increased risk (adjusted odds ratio = 3.0; 95% confidence interval, 1.5–5.7). Approximately 50% of patients required additional therapy or new hospitalisation within 5 years due to a recurrent flare. Death occurred in three patients (0.9%). CONCLUSIONS: Patients with acute severe ulcerative colitis avoiding early colectomy are at risk of long‐term colectomy, especially if previously exposed to antitumour necrosis factor‐α agents or if rescue therapy during the acute attack was required because of steroid refractoriness.
format Online
Article
Text
id pubmed-8259429
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82594292021-07-12 Long‐term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study Festa, Stefano Scribano, Maria L. Pugliese, Daniela Bezzio, Cristina Principi, Mariabeatrice Ribaldone, Davide G. Allocca, Mariangela Mocci, Giammarco Bodini, Giorgia Spagnuolo, Rocco Vernia, Piero Mazzuoli, Silvia Costa, Francesco Barberio, Brigida Cosintino, Rocco Zerboni, Giulia Aratari, Annalisa Armuzzi, Alessandro Papi, Claudio United European Gastroenterol J Inflammatory Bowel Disease BACKGROUND: The long‐term course of ulcerative colitis after a severe attack is poorly understood. Second‐line rescue therapy with cyclosporine or infliximab is effective for reducing short‐term colectomy but the impact in the long‐term is controversial. OBJECTIVE: The purpose of this study was to evaluate the long‐term course of acute severe ulcerative colitis patients who avoid early colectomy either because of response to steroids or rescue therapy. METHODS: This was a multicentre retrospective cohort study of adult patients with acute severe ulcerative colitis admitted to Italian inflammatory bowel disease referral centres from 2005 to 2017. All patients received intravenous steroids, and those who did not respond received either rescue therapy or colectomy. For patients who avoided early colectomy (within 3 months from the index attack), we recorded the date of colectomy, last follow‐up visit or death. The primary end‐point was long‐term colectomy rate in patients avoiding early colectomy. RESULTS: From the included 372 patients with acute severe ulcerative colitis, 337 (90.6%) avoided early colectomy. From those, 60.5% were responsive to steroids and 39.5% to the rescue therapy. Median follow‐up was 44 months (interquartile range, 21–85). Colectomy‐free survival probability was 93.5%, 81.5% and 79.4% at 1, 3 and 5 years, respectively. Colectomy risk was higher among rescue therapy users than in steroid‐responders (log‐rank test, p = 0.02). At multivariate analysis response to steroids was independently associated with a lower risk of long‐term colectomy (adjusted odds ratio = 0.5; 95% confidence interval, 0.2–0.8), while previous exposure to antitumour necrosis factor‐α agents was associated with an increased risk (adjusted odds ratio = 3.0; 95% confidence interval, 1.5–5.7). Approximately 50% of patients required additional therapy or new hospitalisation within 5 years due to a recurrent flare. Death occurred in three patients (0.9%). CONCLUSIONS: Patients with acute severe ulcerative colitis avoiding early colectomy are at risk of long‐term colectomy, especially if previously exposed to antitumour necrosis factor‐α agents or if rescue therapy during the acute attack was required because of steroid refractoriness. John Wiley and Sons Inc. 2021-02-16 /pmc/articles/PMC8259429/ /pubmed/33259773 http://dx.doi.org/10.1177/2050640620977405 Text en © 2020 The Authors. United European Gastroenterology Journal published by Wiley Periodicals LLC. on behalf of United European Gastroenterology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Inflammatory Bowel Disease
Festa, Stefano
Scribano, Maria L.
Pugliese, Daniela
Bezzio, Cristina
Principi, Mariabeatrice
Ribaldone, Davide G.
Allocca, Mariangela
Mocci, Giammarco
Bodini, Giorgia
Spagnuolo, Rocco
Vernia, Piero
Mazzuoli, Silvia
Costa, Francesco
Barberio, Brigida
Cosintino, Rocco
Zerboni, Giulia
Aratari, Annalisa
Armuzzi, Alessandro
Papi, Claudio
Long‐term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study
title Long‐term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study
title_full Long‐term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study
title_fullStr Long‐term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study
title_full_unstemmed Long‐term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study
title_short Long‐term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study
title_sort long‐term outcomes of acute severe ulcerative colitis in the rescue therapy era: a multicentre cohort study
topic Inflammatory Bowel Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259429/
https://www.ncbi.nlm.nih.gov/pubmed/33259773
http://dx.doi.org/10.1177/2050640620977405
work_keys_str_mv AT festastefano longtermoutcomesofacutesevereulcerativecolitisintherescuetherapyeraamulticentrecohortstudy
AT scribanomarial longtermoutcomesofacutesevereulcerativecolitisintherescuetherapyeraamulticentrecohortstudy
AT pugliesedaniela longtermoutcomesofacutesevereulcerativecolitisintherescuetherapyeraamulticentrecohortstudy
AT bezziocristina longtermoutcomesofacutesevereulcerativecolitisintherescuetherapyeraamulticentrecohortstudy
AT principimariabeatrice longtermoutcomesofacutesevereulcerativecolitisintherescuetherapyeraamulticentrecohortstudy
AT ribaldonedavideg longtermoutcomesofacutesevereulcerativecolitisintherescuetherapyeraamulticentrecohortstudy
AT alloccamariangela longtermoutcomesofacutesevereulcerativecolitisintherescuetherapyeraamulticentrecohortstudy
AT moccigiammarco longtermoutcomesofacutesevereulcerativecolitisintherescuetherapyeraamulticentrecohortstudy
AT bodinigiorgia longtermoutcomesofacutesevereulcerativecolitisintherescuetherapyeraamulticentrecohortstudy
AT spagnuolorocco longtermoutcomesofacutesevereulcerativecolitisintherescuetherapyeraamulticentrecohortstudy
AT verniapiero longtermoutcomesofacutesevereulcerativecolitisintherescuetherapyeraamulticentrecohortstudy
AT mazzuolisilvia longtermoutcomesofacutesevereulcerativecolitisintherescuetherapyeraamulticentrecohortstudy
AT costafrancesco longtermoutcomesofacutesevereulcerativecolitisintherescuetherapyeraamulticentrecohortstudy
AT barberiobrigida longtermoutcomesofacutesevereulcerativecolitisintherescuetherapyeraamulticentrecohortstudy
AT cosintinorocco longtermoutcomesofacutesevereulcerativecolitisintherescuetherapyeraamulticentrecohortstudy
AT zerbonigiulia longtermoutcomesofacutesevereulcerativecolitisintherescuetherapyeraamulticentrecohortstudy
AT aratariannalisa longtermoutcomesofacutesevereulcerativecolitisintherescuetherapyeraamulticentrecohortstudy
AT armuzzialessandro longtermoutcomesofacutesevereulcerativecolitisintherescuetherapyeraamulticentrecohortstudy
AT papiclaudio longtermoutcomesofacutesevereulcerativecolitisintherescuetherapyeraamulticentrecohortstudy